-
News & events
-
event, news
October 11-13, 2023 - Amphitheatre, level 2, Duke-NUS Medical School, Singapore
Masterclass: Updates on Vaccine Science
-
news
January 6, 2023 - Singapore
Butantan's dengue vaccine has 79.6% efficacy, partial results from 2-year follow-up
-
news
January 2, 2023 - Singapore
Takeda’s QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
-
news
November 19, 2019 - Singapore
Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) statement on publication of Part 1 results from Takeda's dengue vaccine Phase 3 efficacy trial
-
news
January 30, 2019 - Seoul (South Korea)
GDAC statement on Takeda’s announcement about their Dengue vaccine phase 3 efficacy trial
-
news
November 1-2, 2018 - New Orleans (USA)
2018 GDAC Symposium: Present and Future Dengue Vaccines
-
news
June 13, 2018 - Les Pensieres Center for Global Health, Veyrier-du-Lac (France)
Arboviruses: A Global Public Health Threat
-
news
May 14, 2018 - Lyon (France)
Update by SAGE on the use of the first licenced dengue vaccine, April 2018
-
news
May 11, 2018
GDAC statement on the Strategic Advisory Group of Experts’ (SAGE) updated recommendations on use of Dengvaxia®